Strides Pharma, Inc. is recalling approximately 440,364 cartons of Testosterone Gel 1% (2.5 grams and 5 grams) because of the presence of benzene, a foreign substance. The recall includes 195,952 cartons of the 2.5 gram dose and 244,412 cartons of the 5 gram dose, each containing 30 unit-dose packets per carton. This prescription-only medication is used for testosterone replacement therapy. Benzene is a known human carcinogen that can pose long-term health risks if absorbed into the body. Consumers should check their cartons for specific lot numbers and expiration dates. If you have any remaining medication from the affected lots, you should contact your doctor or pharmacist to discuss alternative treatments.
The product contains benzene, which is classified as a human carcinogen. Exposure to benzene can potentially occur through skin absorption from the topical gel, and long-term exposure is associated with an increased risk of developing cancer and other serious blood disorders.
You have 2 options:
Quantity: 195,952 Cartons
Quantity: 244,412 Cartons
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.